Explore company profiles, quarterly results, announcements and ownership disclosures.
Loading the company view…
Dipna Pharmachem Ltd (NSE: DPL), ISIN INE0MC401013 — earnings, PEAD surprise, concall summary, Walk-the-Talk management consistency, SAST and insider filings, and the EquiSense Score (ECS), all in plain English on EquiSense.
DPL last traded at ₹4.12 (-7.00%), with a 52-week range of ₹3.62 to ₹19.55 (as of 6 Nov 2026).
Shareholding as of Sep 2026: promoters 9.13%, FIIs 0.00%, DIIs 0.00%, mutual funds 0.00%.
EquiSense Score (ECS): 31/100.
Data sourced from NSE and BSE filings. Educational — not investment advice.